Filing Flows

Filing Flows › Heron Therapeutics (HRTX) › Who owns the stock

Who owns Heron Therapeutics (HRTX) stock

164 funds reported Heron Therapeutics (HRTX) shares in their latest 13F filings, worth $68.9M in all. The largest holder is Rubric Capital Management LP ($12.8M). Last quarter 71 funds added to their stakes and 62 cut them.

Largest holders of HRTX (13F)Largest holders of HRTX (13F)Rubric Capital Management LP$12.8MVanguard Group$12.8MClearline Capital LP$4.9MBlackRock$4.5MVelan Capital Investment Manageme…$3.7MVanguard Capital Management LLC$3.3MTejara Capital$2.8MTang Capital Management LLC$2.7MGeode Capital Management, LLC$1.8MMillennium Management LLC$1.7M

Largest holders (13F)

FundSharesValueChangeQuarter
Rubric Capital Management LP30,046,828$12.8Munchanged2026-06-30
Vanguard Group9,820,384$12.8Mincrease2025-12-31
Clearline Capital LP11,383,961$4.9Mdecrease2026-06-30
BlackRock10,550,750$4.5Mincrease2026-06-30
Velan Capital Investment Management LP8,753,290$3.7Munchanged2026-06-30
Vanguard Capital Management LLC7,782,741$3.3Mdecrease2026-06-30
Tejara Capital6,510,795$2.8Mincrease2026-06-30
Tang Capital Management LLC6,250,000$2.7Munchanged2026-06-30
Geode Capital Management, LLC4,270,980$1.8Mincrease2026-06-30
Millennium Management LLC4,070,101$1.7Mdecrease2026-06-30
JW Asset Management, LLC3,751,073$1.6Munchanged2026-06-30
State Street3,228,557$1.4Mdecrease2026-06-30
UBS Group AG2,997,073$1.3Mincrease2026-06-30
Pale Fire Capital SE2,511,478$1.1Mdecrease2026-06-30
Marshall Wace, LLP2,354,193$1.0Mnew2026-06-30

Heron Therapeutics' latest quarter

Heron Therapeutics, Q2 2026: revenue $37.7M (+1% year over year), operating margin -5.4%, net loss $5.5M, operating cash flow −$2.2M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most HRTX stock?

By the latest 13F filings: Rubric Capital Management LP ($12.8M); Vanguard Group ($12.8M); Clearline Capital LP ($4.9M); BlackRock ($4.5M); Velan Capital Investment Management LP ($3.7M).

What is the short interest in HRTX?

36,741,075 shares were sold short at the 2026-10-15 settlement, -20.17% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.